pharmacogenomics

Scientists explain how they are making therapeutics “intelligent”

UCSF scientists describe how their research is aiming to make therapeutics sophisticated, highly effective, and tailored to the different needs of individuals.

Giacomini and Peck honored with ASCPT awards

Kathy Giacomini, PhD, and Carl Peck, MD, faculty members in the UCSF Department of Bioengineering and Therapeutic Sciences (BTS), received awards from the American Society for Clinical Pharmacology and Therapeutics (ASCPT) at the society's annual meeting held in National Harbor, Maryland, USA,...

Pharmacogenomics research spans school agenda

Pharmacogenomics research at the UCSF School of Pharmacy extends from a better understanding of information derived from the Human Genome Project to research on specific genetic differences in humans and how they might affect an individual's response to a medication. It covers clinical research...

Kroetz uses pharmacogenetics to determine the best treatment options for leukemia patients

Some leukemia cells supercharge cell pumps to get rid of chemotherapy. UCSF School of Pharmacy faculty member and pharmacogenetics researcher Deanna Kroetz, PhD, is aiming toward a simple way to identify these tumors, select the best treatment and avoid complications.

Full story

[Leukemia...

Giacomini receives Dawson Award

Kathy M. Giacomini, PhD, UCSF School of Pharmacy scientist, received the 2005 Paul Dawson Biotechnology Award in Cincinnati, Ohio on July 10, 2005 from the American Association of Colleges of Pharmacy (AACP). The award recognizes exceptional teaching and research in biotechnology.

Giacomini and Benet honored by international peers

Kathy M. Giacomini, PhD, chair, department of biopharmaceutical sciences and Leslie Z. Benet, PhD, professor in the same department, were both honored at the Pharmaceutical Sciences World Congress, held May 29 to June 4, 2004 in Kyoto, Japan.

Pages